Not Yet Recruiting
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
NCT07691970
- Conditions
- Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Fort Lauderdale, Florida, United States
- Research Site Chicago, Illinois, United States
- Research Site Ann Arbor, Michigan, United States